ChemicalBook >> CAS DataBase List >>Tirofiban hydrochloride monohydrate

Tirofiban hydrochloride monohydrate

CAS No.
150915-40-5
Chemical Name:
Tirofiban hydrochloride monohydrate
Synonyms
Tirofiban HCl;Tirofiban hcl Monohydrate;MK-0383;682-504-6;Unii-6H925F8o5j;MK-383 Hydrochloride;Tirofiban HCl Hydrate;irofibanhydrochloride;TirofibanHcl142373-60-2/;Tirofiban Hydrochiloride
CBNumber:
CB7506819
Molecular Formula:
C22H39ClN2O6S
Molecular Weight:
495.07
MDL Number:
MFCD07368623
MOL File:
150915-40-5.mol
Last updated:2024-03-12 13:29:27

Tirofiban hydrochloride monohydrate Properties

Melting point 135-137°C
storage temp. -20°C
solubility DMSO: >12mg/mL at warmed to 60°C
form powder
color white to beige
optical activity [α]/D -10 to -18° (c=1, MeOH)
Merck 14,9464
FDA UNII 6H925F8O5J

SAFETY

Risk and Safety Statements

Symbol(GHS)  GHS hazard pictograms
GHS07
Signal word  Warning
Hazard statements  H315-H319-H335
Precautionary statements  P261-P264-P271-P280-P302+P352-P305+P351+P338
Hazard Codes  Xi
Risk Statements  36/37/38
Safety Statements  26-37-45
WGK Germany  3
HS Code  2935.90.6000
NFPA 704
0
2 0

Tirofiban hydrochloride monohydrate price More Price(45)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich SML0246 Tirofiban hydrochloride monohydrate ≥98% (HPLC) 150915-40-5 10mg $110 2024-03-01 Buy
Sigma-Aldrich SML0246 Tirofiban hydrochloride monohydrate ≥98% (HPLC) 150915-40-5 50mg $441 2024-03-01 Buy
TCI Chemical T3640 Tirofiban Hydrochloride Monohydrate >98.0%(HPLC) 150915-40-5 50mg $267 2024-03-01 Buy
TCI Chemical T3640 Tirofiban Hydrochloride Monohydrate >98.0%(HPLC) 150915-40-5 250mg $928 2024-03-01 Buy
Alfa Aesar H37492 Tirofiban hydrochloride monohydrate 98% 150915-40-5 1g $0 2021-12-16 Buy
Product number Packaging Price Buy
SML0246 10mg $110 Buy
SML0246 50mg $441 Buy
T3640 50mg $267 Buy
T3640 250mg $928 Buy
H37492 1g $0 Buy

Tirofiban hydrochloride monohydrate Chemical Properties,Uses,Production

Tirofiban hydrochloride monohydrate

Tirofiban is an anti-angina drug, it is successfully developed by the United States Merck company , Patent Number is EP 478363, and in 1998 it was sold in the United States, the trade name is Aggrastat,it is clinically used in treating acute coronary syndromes, including unstable angina or non-Q-wave myocardial infarction, and percutaneous transluminal coronary angioplasty (PTCA) or atherosclerotic plaque excision patients with in combination with heparin.
Drugs currently used in clinical are mainly tirofiban hydrochloride injections under the tradename Xin Weining, it is a reversible non-peptide platelet surface glycoprotein (GP) Ⅱb/Ⅲa receptor antagonist, it can competitively inhibit combination of fibrinogen and platelet (GP) Ⅱb/Ⅲa receptor . Intravenous injection is a dose-dependent inhibition of outside human platelet aggregation, prolonged bleeding time,and thrombosis caused by ADP, collagen, arachidonic acid,thromboxane analog U46619 and thrombin.
In healthy volunteers ,they are injected in routinely recommended doses, the peak plasma concentration is similar to that of steady-state plasma concentrations during the infusion ,T1/2 is 2h. Within 0.01~25 μg/ml dose range, PPB of this product is 65%, independent of concentration. Free drug accounts for 35% in plasma, Vd is 22~42 L. In healthy volunteers, CL is 213~314 ml/min, the renal clearance rate is 39%-69% of plasma clearance.
[Usage ]
(1) tirofiban hydrochloride monohydrate in combination with heparin is used in treating acute coronary syndromes, including unstable angina or non-Q-wave myocardial infarction, and percutaneous transluminal coronary angioplasty (PTCA) or atherectomy artery surgery patients.
(2) to give this product 0.4μg/(kg · min) bolus, 300 min, followed by a maintenance dose of 0.1μg/(kg · min). Unstable angina or non-Q-wave myocardial infarction patients need an infusion of 48~108 h. Row PTCA or atherectomy arterial patients need to continue infusion 12~24 h after surgery.
The above information is edited by the chemicalbook of Tian Ye.

Precautions

1. Adverse reactions: The most common adverse reactions are fever, or bleeding complications; other visible adverse reactions are nausea, headache, rash or urticaria, systemic reactions visible is reduction in platelet count.
2. Disable: allergy to the drug, the use of tirofiban in patients with thrombocytopenia occurring, there is active bleeding or bleeding constitution history before 30 days, history of intracranial hemorrhage, nearly a month of stroke or brain hemorrhage stroke, intracranial tumors, aneurysms, arteriovenous malformations, vital organs, surgery or severe trauma requiring surgical treatment, patients with aortic dissection, pericarditis, severe hypertension.
3. caution: recent (1 year) bleeding in patients, with coagulopathy, platelet disorder, or a history of thrombocytopenia, platelet count less than 150 × 109/L patients who have a history of cerebrovascular disease (1 year) , with recent subdural extracapsular surgery, nearly a month having a major surgery or a history of severe physical trauma, dissecting aneurysm, hemorrhagic retinal diseases, chronic hemodialysis patients.

Uses

Acute coronary syndrome (angina pectoris, myocardial infarction, surgery hydrant).
Tirofiban hydrochloride monohydrate is a potent non-peptide, glycoprotein IIb/IIIa inhibitor. It can prevent platelet aggregation and thrombosis.

Chemical Properties

White Solid

Uses

Tirofiban hydrochloride monohydrate has been used as an αIIbβ3 integrin (glycoprotein IIb/IIIa) inhibitor for mouse induced pluripotent stem cell (iPSC) culture.

Uses

A specific nonpeptide platelet fibrinogen receptor (GPIIb/IIIa) antagonist. An antithrombotic used in the treatment of unstable angina

Uses

Tirofiban is a specific nonpeptide platelet fibrinogen receptor (GPIIb/IIIa) antagonist. Tirofiban is an antithrombotic used in the treatment of unstable angina.

Definition

ChEBI: Tirofiban hydrochloride is a hydrochloride. It contains a tirofiban.

Biochem/physiol Actions

Tirofiban hydrochloride is a potent non-peptide, glycoprotein IIb/IIIa inhibitor. Blocks platelet aggregation and thrombus formation.

Tirofiban hydrochloride monohydrate Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 279)Suppliers
Supplier Tel Email Country ProdList Advantage
Shanghai Joiny Pharmaceutical Co.,LTD
+8613681955282 gyd@joiny-pharma.com China 228 58
Changzhou Rokechem Technology Co., Ltd.
18758118018 sales001@rokechem.com China 255 58
Henan Bao Enluo International TradeCo.,LTD
+86-17331933971 +86-17331933971 deasea125996@gmail.com China 2503 58
Beijing Cooperate Pharmaceutical Co.,Ltd
010-60279497 sales01@cooperate-pharm.com CHINA 1811 55
Hangzhou FandaChem Co.,Ltd.
008657128800458; +8615858145714 fandachem@gmail.com China 9352 55
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795 ivan@atkchemical.com China 32480 60
career henan chemical co
+86-0371-86658258 sales@coreychem.com China 29914 58
Hubei xin bonus chemical co. LTD
86-13657291602 linda@hubeijusheng.com CHINA 22968 58
BOC Sciences
+1-631-485-4226 inquiry@bocsci.com United States 19553 58
Chongqing Chemdad Co., Ltd
+86-023-61398051 +8613650506873 sales@chemdad.com China 39916 58

View Lastest Price from Tirofiban hydrochloride monohydrate manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
N-(Butylsulfonyl)-O-(4-(4-piperidinyl)butyl)-L-tyrosine monohydrochloride monohydrate pictures 2024-04-10 N-(Butylsulfonyl)-O-(4-(4-piperidinyl)butyl)-L-tyrosine monohydrochloride monohydrate
150915-40-5
US $0.00 / kg 1kg 98% 500kg Shanghai Joiny Pharmaceutical Co.,LTD
Tirofiban hydrochloride monohydrate pictures 2023-07-27 Tirofiban hydrochloride monohydrate
150915-40-5
US $10.00 / kg 1kg 99% 1000tons Henan Bao Enluo International TradeCo.,LTD
 Tirofiban hydrochloride pictures 2023-06-28 Tirofiban hydrochloride
150915-40-5
US $0.00-0.00 / Kg 1Kg 99%;USP/EP/CP 1-10000kgs Changzhou Rokechem Technology Co., Ltd.

Tirofiban hydrochloride monohydrate Spectrum

TIROFIBAN, HYDROCHLORIDE HYDRATE TirofibanHcl142373-60-2/ N-(Butylsulfonyl)-O-[4-(4-piperidynyl)butyl]-L-tyrosine, Hydrochloride Hydrate (2S)-2-(Butylsulfonylamino)-3-[4-[4-(4-piperidyl)butoxy]phenyl]propanoic acid hydrochloride hydrate N-(Butylsulfonyl)-O-(4-(4-piperidinyl)butyl)-L-tyrosine monohydrochloride monohydrate Tirofiban hydrochloride monohydrate 4-(4-Pyridinyl)butanol hydrochloride L-Tyrosine, N-(butylsulfonyl)-o-(4-(4-piperidinyl)butyl)-, monohydrochloride, monohydrate Unii-6H925F8o5j Tirofiban hydrochloride monohydrate N-(Butylsulfonyl)-O-(4-(4-piperidinyl)butyl)-L-tyrosine monohydrochloride monohydrate (S)-2-(butylsulfonamido)-3-(4-(4-(piperidin-4-yl)butoxy)phenyl)propanoic acid hydrochloride hydrate Tirofiban HCl Hydrate MK-0383 MK-383 Hydrochloride irofibanhydrochloride Tirofiban hydrochloride monohydrate USP/EP/BP Tirofiban Hydrochloride Impurities Tirofiban hydrochloride hydrate (MK-383) 682-504-6 Tirofiban HydrochlorideQ: What is Tirofiban Hydrochloride Q: What is the CAS Number of Tirofiban Hydrochloride Q: What is the storage condition of Tirofiban Hydrochloride Q: What are the applications of Tirofiban Hydrochloride Tirofiban HCl Tirofiban hcl Monohydrate Tirofiban Hydrochiloride 150915-40-5 Cardiovascular APIs Inhibitors Intermediates & Fine Chemicals Pharmaceuticals API 150915-40-5